Life

Share
20th March 2019
06:36pm GMT

"Someone on my team bought postpartum psychosis to my attention, and if I’m entirely honest, I don’t think I knew much about it. I’d heard of postnatal depression before, but this was a new one for me. It affects about one in every 500 new mums, and symptoms include visual and auditory hallucinations, as well as profoundly irrational and disordered thoughts. It seemed to me to be a story we could do justice to".
Postpartum depression impacts some women after they give birth and it can manifest itself in a number of ways, both physically and mentally. Today, the US Food and Drug Administration has approved brexanolone, a drug which will be sold as Zulresso, for the treatment of postpartum depression. In clinical trials, it showed evidence of working within hours and experts hope it will provide relief for those who suffer from this type of depression. This is a huge step forward in terms of helping women and their families through what can be a devastating time.As someone who experienced elements of postpartum psychosis, I’m thrilled that it’s @louistheroux who is exploring this extremely sensitive issue. I really hope I find the strength to watch it. https://t.co/A34Gm4NK8c
— Nicki (@nkeadon) March 20, 2019
Explore more on these topics: